Compare Sumber Mineral Global Abadi Tbk. (SMGA) vs Zyrexindo Mandiri Buana Tbk. (ZYRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sumber Mineral Global Abadi Tbk. vs Zyrexindo Mandiri Buana Tbk. — how do they compare? Sumber Mineral Global Abadi Tbk. trades at Rp76 (market cap 638.75B, 21.58M 24h volume), while Zyrexindo Mandiri Buana Tbk. trades at Rp129 (market cap 173.33B, 1.04M 24h volume). The key difference: Sumber Mineral Global Abadi Tbk. is far larger — about 3.7× Zyrexindo Mandiri Buana Tbk.'s market cap, and Sumber Mineral Global Abadi Tbk. is more actively traded (21.58M versus 1.04M). Which is the better fit depends on your goals.
| SMGA | ZYRX | |
|---|---|---|
Market Cap | 638.75B | 173.33B |
Volume | 21.58M | 1.04M |
Lot | 215.82K | 10.41K |
Turnover | 1.58B | 134.49M |
Average Price | 73.21 | 129.19 |
Value | 1.58B | 134.49M |
Indicative Equilibrium Price | 76 | 129 |
Indicative Equilibrium Volume | 12.3K | 15 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sumber Mineral Global Abadi Tbk.
PT Sumber Mineral Global Abadi Tbk (the Company) was established based on Notarial Deed No. 2 dated October 19, 2016 of Selina Bertha Eny, S.H., a notary in South Tanggerang. The Company started its commercial operations in 2016. The Company’s immediate and ultimate parententities are PT Sumber Global Energy Tbk and PT Sumbermas Inti Energi, respectively, both entities domiciled in Jakarta. The controlling interest of the Company is PT Sumber Global Energy Tbk.
Read more on SMGA →About Zyrexindo Mandiri Buana Tbk.
PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Read more on ZYRX →
